Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae

Shigeki Nakamura1, Mikhail Shchepetov, Ankur B Dalia

  • 1Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Plos Pathogens
|January 22, 2011
PubMed

Insights

Non-typeable Haemophilus influenzae (NTHi) develops serum resistance in the lower respiratory tract by altering its outer membrane. This adaptation helps NTHi evade immune responses during chronic obstructive pulmonary disease exacerbations.

Area of Science:

  • Microbiology
  • Immunology
  • Bacterial Pathogenesis

Background:

  • Non-typeable Haemophilus influenzae (NTHi) is a common bacterium that can cause lower respiratory tract (LRT) infections, particularly during chronic obstructive pulmonary disease (COPD) exacerbations.
  • Isolates from the LRT exhibit greater resistance to serum's bactericidal effects compared to upper airway colonizers.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying serum resistance in NTHi isolates from the LRT.
  • To identify bacterial genes and pathways involved in NTHi's survival against serum-mediated immune responses.

Main Methods:

  • Construction and screening of mariner transposon mutants in a serum-resistant NTHi strain for loss of serum survival.
  • Analysis of bacterial outer membrane composition, stability, hydrophobicity, and phospholipid content in wild-type and mutant strains.
  • Assessment of natural immunoglobulin M and monoclonal antibody binding to bacterial surface.

Main Results:

  • Mutations in loci involved in lipooligosaccharide (LOS) biosynthesis and the vacJ/yrb genes conferred serum sensitivity.
  • VacJ and yrb gene products are crucial for outer membrane stability and regulate phospholipid trafficking.
  • VacJ and yrb mutants showed increased cell surface hydrophobicity and phospholipid content, leading to reduced serum resistance.
  • Serum-resistant NTHi isolates demonstrated higher expression of vacJ and yrb genes.

Conclusions:

  • NTHi adapts to the inflammatory LRT environment by modulating its outer membrane composition, specifically through the vacJ and yrb genes.
  • Upregulation of vacJ and yrb enhances outer membrane stability and reduces recognition by bactericidal antibodies, contributing to NTHi's persistence in the LRT.
  • These findings provide insights into NTHi pathogenesis and potential therapeutic targets for LRT infections.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...